Crossmark

Is interleukin-1 blockade a therapeutic option for patients with palindromic rheumatism?

Crossref DOI link: https://doi.org/10.1007/s10067-024-07038-8

Published Online: 2024-06-29

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jeries, Helana https://orcid.org/0000-0001-8624-6332
Daood, Rula

Naffaa, Mohammad E. https://orcid.org/0000-0001-9777-2864
License Information

Text and Data Mining valid from 2024-06-29

Version of Record valid from 2024-06-29
More Information

Article History

Received: 25 May 2024

Revised: 19 June 2024

Accepted: 20 June 2024

First Online: 29 June 2024

Declarations

:

: A patient’s written informed consent was obtained.

: None.